Multiple sclerosis: Advances in diagnosis, biomarkers, and disease management.
Multiple sclerosis (MS) care has advanced rapidly across diagnosis, biomarkers, and disease-modifying therapy. The 2024 revision of the McDonald criteria enables earlier and more biologically grounded diagnosis through the cerebrospinal fluid (CSF) kappa free light chain (KFLC) index, the central vein sign (CVS), and p...